The expression of surface markers CD34, CD38, CD117, CD133 in BMMC from all 39 MDS cases studied was evaluated before and after incubation in 0.1% O2 or in normoxia (Figure 3). This evidence concerns the gene PROM1 and myelodysplastic syndrome.